Fig. 2: Immunohistochemistry to detect SMARCAL1.
From: SMARCAL1 loss and alternative lengthening of telomeres (ALT) are enriched in giant cell glioblastoma
IHC for SMARCAL1 was performed on U87 cell line variants, either SMARCAL1 wild-type (A) or SMARCAL1 knockout (B). C Example of giant cell GBM lacking SMARCAL1 protein expression in the cancer cells as revealed by IHC. For all panels, original magnification ×400.
